Orchestra BioMed Holdings Inc. (OBIO) Stock Analysis

Orchestra BioMed Holdings Inc. (OBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $3.91, carries a market capitalization of $229.34M. This page summarizes the public market data, fundamentals, and frequently asked questions for OBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.91
• Market Cap: $229.34M
• EPS: $-0.95
• 52-Week High: $5.42
• 52-Week Low: $2.20

Market Sentiment

Orchestra BioMed Holdings Inc. currently has a Neutral sentiment score of 0.03.

About Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings, Inc. is a pioneering therapeutic device company based in New Hope, Pennsylvania, dedicated to advancing treatments for cardiovascular diseases through its innovative product line. Utilizing proprietary technologies, the company addresses crucial unmet clinical needs, significantly enhancing patient outcomes and therapeutic approaches in cardiology. With a strong commitment to improving healthcare access and quality, Orchestra BioMed positions itself as an emerging l...

GNG Research Analysis

GNG Research scores Orchestra BioMed Holdings Inc. (OBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OBIO.

Frequently Asked Questions

Does OBIO pay dividends?

Orchestra BioMed Holdings Inc. (OBIO) does not currently pay a regular dividend.

What is OBIO's market cap?

Orchestra BioMed Holdings Inc. (OBIO) has a market capitalization of $229.34M with a current stock price of $3.91.